More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

Semaglutide is not the only medication in this drug class. Eli Lilly has developed its own GLP-1 receptor agonist, ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re pregnant or hoping to become pregnant, it’s ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Sun Pharma receives DCGI approval to launch generic Wegovy semaglutide in India after patent expiry in March 2026. Check ...

GoodRx reports transitioning from injectable to oral GLP-1s can simplify weight loss routines, but requires careful timing and consistency.

The SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already taking metformin. The primary aim was ...

Biomed Industries, Inc. Announces Two NA-931 Phase 3 Trials, Targeting Durable Weight Loss & Lean-Mass Preservation ...

Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the ...

Approval clears the regulatory path for a lower-cost GLP-1 weight-loss drug in India, but commercial launch hinges on semaglutide patent expiry.